-
The ASAM Weekly for December 31st, 2024
ASAM Weekly Top 10 News Articles of 2024Full story -
The ASAM Weekly for December 24th, 2024
ASAM Weekly Top 10 Peer-Reviewed Scientific Publications of 2024Full story -
Congress Misses Crucial Opportunity to Include Lifesaving Addiction Treatment Legislation in Year-End Package; ASAM Calls for Immediate Action in 2025
Full story -
ASAM Joins Letter Calling to End $75 Contingency Management Restriction
Full story -
VASAM Comments on Proposed Buprenorphine Treatment Regulations
Full story -
The ASAM Weekly for December 17th, 2024
The impact of schizophrenia genetic load and heavy cannabis use on the risk of psychotic disorderFull story -
COSAM Supports Removing Restrictions on SSPs in Denver
Full story -
ASAM Encourages CMS to Strengthen Medicaid Parity Regulations
Full story -
ASAM Joins Letter Requesting Federal Best Practices to Protect Youth Amidst Marijuana Legalization in States
Full story -
The ASAM Weekly for December 3rd, 2024
Xylazine Pharmacokinetics in Patients Testing Positive for Fentanyl and XylazineFull story -
The ASAM Weekly for November 26th, 2024
Women, gender and drugsFull story -
ASAM Calls on Congress to Pass the Reentry Act and Due Process Continuity of Care Act
Full story -
Biden Administration Issues Third Temporary Extension of Telemedicine Flexibilities Through December 2025; ASAM Urges More Decisive Action to Expand Access to Lifesaving Addiction Treatments
Full story -
ASAM Voices Support for Legislation to Encourage Adoption of Integrated Care Models
Full story -
The ASAM Weekly for November 19th, 2024
How to survive enormous amounts of alcoholFull story -
Amid Overdose Crisis, Leadership Shifts, and a Renewed Focus on Empowering Physicians and Patients, Stakeholders Urge Congress to Pass the Modernizing Opioid Treatment Access Act (S. 644/H.R. 1359)
Full story -
The ASAM Weekly for November 5th, 2024
Links between adolescent binge drinking and midlife alcohol useFull story -
Medicare Finalizes New Payment Policies for 2025
Medicare Finalizes New Payment Policies for 2025Full story -
COSAM Supports Proposal to Prohibit Flavored Tobacco Products in Denver
COSAM Supports Proposal to Prohibit Flavored Tobacco Products in DenverFull story -
Reports of Refusals to Fill Buprenorphine Prescriptions Hits New High, but Overall Reports Down
Reports of Refusals to Fill Buprenorphine Prescriptions Hits New High, but Overall Reports DownFull story